Showing results (801-810 of 826) with videos related to

Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2019
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal CancerFilippo Pietrantonio, Riccardo Lobefaro, Maria Antista, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Cancers|January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.
Giornale Italiano Di Cardiologia (2006)|May 9, 2023
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention]Pasquale Guarini, Francesco Saia, Milena Sidiropulos, et al.
Advances in Hematology|February 7, 2022
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb StudyMario Petrini, Gianluca Gaidano, Andrea Mengarelli, et al.
Annals of Hematology|January 11, 2026
Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care?Francesco Tarantini, Corinne Contento, Ernesto Vigna, et al.
Blood Advances|June 5, 2023
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trialRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2024
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repairValeria Magni, Marianna Adamo, Elisa Pezzola, et al.
Lancet (London, England)|September 22, 2009
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trialAndrés J M Ferreri, Michele Reni, Marco Foppoli, et al.
Annals of Hematology|November 8, 2020
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)Anna Mele, Eleonora Prete, Clara De Risi, et al.
Pageof 83